title: [Inhibitory effects of cyclooxygenase-2 selective inhibitor Celecoxib on human nephroblastoma].
authors.affiliation: huxiaoli788@126.com
authors.forename: Xiao-li
authors.initials: XL
authors.lastname: Hu
authors.forename: Lin-sheng
authors.initials: LS
authors.lastname: Zhao
authors.forename: Wei
authors.initials: W
authors.lastname: Liu
authors.forename: Jian-bo
authors.initials: JB
authors.lastname: Shu
authors.forename: Li
authors.initials: L
authors.lastname: Xu
authors.forename: Zhen-fang
authors.initials: ZF
authors.lastname: Wang
mesh_terms: D000068579:Celecoxib; D002453:Cell Cycle / Q000187:drug effects; D045744:Cell Line, Tumor; D049109:Cell Proliferation / Q000187:drug effects; D019941:Cyclin-Dependent Kinase Inhibitor p16 / Q000235:genetics / Q000378:metabolism; D050759:Cyclin-Dependent Kinase Inhibitor p21 / Q000235:genetics / Q000378:metabolism; D052246:Cyclooxygenase 2 Inhibitors / Q000008:administration & dosage / Q000494:pharmacology*; D004305:Dose-Response Relationship, Drug; D006801:Humans; D007680:Kidney Neoplasms / Q000378:metabolism / Q000473:pathology*; D011720:Pyrazoles / Q000008:administration & dosage / Q000494:pharmacology*; D012333:RNA, Messenger / Q000378:metabolism; D013449:Sulfonamides / Q000008:administration & dosage / Q000494:pharmacology*; D009396:Wilms Tumor / Q000378:metabolism / Q000473:pathology*
chemical_list: C493956:CDKN1A protein, human; D019941:Cyclin-Dependent Kinase Inhibitor p16; D050759:Cyclin-Dependent Kinase Inhibitor p21; D052246:Cyclooxygenase 2 Inhibitors; D011720:Pyrazoles; D012333:RNA, Messenger; D013449:Sulfonamides; D000068579:Celecoxib